Keyphrases
2 Polymorphism
10%
Adipokines
21%
Anti-inflammatory Cytokines
75%
Anti-inflammatory Response
32%
Antitumor
21%
Breast Cancer Risk
10%
Cancer Cases
10%
Case-cohort Study
42%
Chronic Inflammation
42%
Colorectal Cancer
75%
Colorectal Cancer Risk
53%
Cytokine Receptor
10%
Endometrial Cancer
10%
Estradiol
10%
Estrogen
10%
Etiology
21%
Existing Data
10%
Gene Polymorphism
10%
High-risk Individuals
32%
Inflammatory Cytokines
75%
Inflammatory Tumor
14%
Insulin
21%
Insulin-like Growth factor-1
21%
Interactive Effects
10%
Interferon-γ
21%
Interleukin-1 Receptor Antagonist (IL-1Ra)
21%
Interleukin-1Ra
10%
Interleukin-1β
21%
Interleukin-6
21%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
32%
Plasma Parameters
10%
Postmenopausal Women
42%
Public Health
10%
Serologic
10%
Signal Transduction Pathway
10%
Soluble Cytokine Receptor
10%
TNF Receptor 1 (TNFR1)
21%
TNF Receptor 2 (TNFR2)
10%
Tumor Development
32%
Tumor Necrosis Factor-α
21%
Women's Health Initiative
10%
Immunology and Microbiology
Adipokine
40%
Blood Level
20%
Cytokine
80%
Cytokine Receptor
40%
Inflammation Response
60%
Inflammatory Cytokine
100%
Interferon Gamma
40%
Interleukin
20%
Interleukin 1
40%
Interleukin 1 Receptor Antagonist
20%
Interleukin 6
40%
Postmenopause
80%
Proinflammatory Cytokine
100%
Signal Transduction
20%
Tumor Necrosis Factor
40%
Tumor Necrosis Factor Receptor 1
20%
Tumor Necrosis Factor Receptor 2
20%
Women's Health
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adipocytokine
12%
Anti-Inflammatory Drug
75%
Breast Cancer
6%
Chronic Inflammation
24%
Cohort Study
24%
Colorectal Cancer
75%
Cytokine
75%
Cytokine Receptor
12%
Diethylstilbestrol
6%
Endometrium Cancer
6%
Gamma Interferon
12%
Inflammation
18%
Interleukin 1
12%
Interleukin 1 Receptor Blocking Agent
12%
Interleukin 6
12%
Neoplasm
31%
Prospective Study
6%
Tumor Necrosis Factor
12%
Tumor Necrosis Factor Receptor 1
6%
Tumor Necrosis Factor Receptor 2
8%